Direct-to-Consumer Laboratory Testing Market

Direct-to-Consumer Laboratory Testing Market (Sample Type: Blood, Urine, Saliva, and Others; Test Type: Genetic Testing, Disease Risk Assessment Testing, CBC, Diabetes Testing, TSH Testing, and Others; and End User: Hospitals, Clinics, Specialty Labs, and Diagnostic Centers) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

Conducting Several Types of Test with User Convenience Rapidly Attracting New Consumers

The direct-to-consumer (DTC) laboratory testing is an efficient way for consumers to order tests directly from a laboratory without having to work with their healthcare providers. The healthcare industry is shifting their focus from being physician-focused to being consumer-focused. Thus, the DTC lab testing is one of the manifestations of the healthcare sector dreamed in the mid-1900s. An increasing number of patients are moving toward the idea of getting tested without having to go through a lengthy in-clinic process, which is fueling the global direct-to-consumer laboratory testing market. The test results are used to identify previously unknown medical disorders by monitoring an existing health condition. It also helps to access data about personal health aspects. The advancement in DTC lab testing is very essential to increase patient's and individual's engagement in monitoring their healthcare. Thus, it is crucial for laboratory professionals to upgrade their equipment timely to provide precise test results with full understanding.

Presently, many laboratories that offer DTC laboratory testing provide basic tests such as chemistry panels, complete blood count (CBC), pregnancy test, diabetes screening, and blood typing. According to healthcare guidelines in some nations, screening tests can be allowed to facilitate the early detection of diseases. The test helps people to monitor disease and obtain treatment accordingly. Additionally, the tests come provided with descriptions of benefits, risks, and conditions that are also easily understood. The tests offered by DTC laboratories are often waived tests to ensure a low risk of receiving incorrect results. The development in DTC testing has enabled consumers to buy OTC test kits to collect the sample and mail it to a laboratory that performs the test. Growing consumer convenience and rise in awareness among consumers are driving the demand for the global direct-to-consumer laboratory testing market during the forecast period.

Request a sample to get extensive insights into the Direct-to-Consumer Laboratory Testing Market

DTC Tests Prove Crucial in Critical Response Plan to Fight against COVID-19

The global market in the year 2020 experienced a vast slowdown in almost every industry, owing to the COVID-19 pandemic. Major businesses were asked to postpone or shut their projects in order to contain the spread of coronavirus. Lockdowns, restraint in the supply chain, limited industrial work, and restrictions on the global import-export were implemented by several governments, which hampered industrial growth across the world. However, DTC testing continues to be the backbone in the fight against the coronavirus disease, maintaining containment efforts to decrease the outbreak. The severity of this pandemic and expanding capacity issues linked with the polymerase chain reaction (PCR)-based testing expedited the development of diagnostic solutions to fulfill the demand for mass testing. Various tests of in-vitro diagnostics, including molecular and immunological tests, were the primary focus of DTC testing innovations, which kept the direct-to-consumer laboratory testing market moving through the pandemic in spite of limited resources to perform the tests.

The direct-to-consumer laboratory testing market witnessed an increasing demand for rapid and easy-to-use tests to promote testing outside of laboratory settings. This resulted in the development of immunological tests to detect the presence of viral surface antigens utilizing an antibody. The COVID-19 pandemic caused by the severe acute respiratory syndrome CoV-2 presented an unusual global challenge that reshaped the exercises across the DTC testing innovation landscape. However, the direct-to-consumer laboratory testing market has witnessed a growth in demand amidst the pandemic and is further expected to expand with several people becoming familiar with the process. Furthermore, the growing prevalence of infectious diseases is one of the major factors driving market demand in the post COVID-19. The COVID-19 outbreak similar to other highly contagious infections has led to the rapid development and adoption of DTC testing as part of the critical response plan, propelling the direct-to-consumer laboratory testing market.

To understand how our report can bring difference to your business strategy, Ask for a brochure

Growing Consumer Preference to Perform Tests with Confidentiality Boosts Market Growth

The DTC testing is an interesting extension to the traditional healthcare model for customers desiring information of their health situation and disease risk, ancestry, and their body's expected response to certain prescriptions based on their genotype. The advantages of DTC testing are enticing and driving the direct-to-consumer laboratory testing market. The traditional model of laboratory testing in healthcare begins with the patient identifying the need to see a doctor. Waiting for test results and interpretative data from their doctor can be a source of stress. Reasonably, consumers are ready for a new healthcare model with increased convenience and detailed diagnostic reports without having to go through lengthy procedures. Moreover, the direct-to-consumer laboratory testing menu is ever-expanding, and DTC tests are promoted for a variety of uses. Typical sample types are cheek swabs, saliva or spit, urine, hair, blood spots, or blood. Moreover, there are thousands of DTC tests presently available with more being developed. One common test is DTC genetic tests, which use a saliva sample and is analyzed by genotyping.

The difficulty of scheduling and waiting for an appointment with physician conflicts with consumers' lifestyles. In-office wait times can be long and are negatively associated with patient satisfaction and the likelihood to recommend a physician. On the contrary, DTC companies allow testing without an appointment. Many businesses also offer telehealth benefits for consumers to discuss lab results with a medical professional. Additionally, another appeal of DTC lab tests is confidentiality. Results cannot be shared with anyone unless patients share the result themselves. People may feel more comfortable attempting out testing options for sexually transmitted infections, screening for drugs of abuse, reproduction, and fertility-related tests when the results will be confidential. All these factors are most likely to fuel the demand for the global direct-to-consumer laboratory testing market during the projected timeline.

North America to Lead Direct-to-Consumer Laboratory Testing Market

The rising prevalence of lifestyle-associated and contagious diseases in North America is likely to drive the direct-to-consumer laboratory testing market during the forecast period. Furthermore, increasing consumer awareness and enhancing lifestyles in Europe are expected to boost the direct-to-consumer laboratory testing market in the region.  In addition, the increase in government initiatives to promote enhanced, user-friendly diagnostics and genetic research in countries across Asia is expected to fuel the growth of the direct-to-consumer laboratory testing market.

The global direct-to-consumer laboratory testing market is projected to expand at a CAGR of 25.9% from 2021 to 2031.

Stuck in a neck-to-neck competition with other brands? Request a custom report on Direct-to-Consumer Laboratory Testing Market

Analysts’ Viewpoint

The modern world demand increased convenience in the everyday aspect of life, including lifecare. With technology becoming smart and people becoming smarter, several consumers seek more control over their health and are willing to pay for DTC service to save time and effort. However, consumers must weigh the recognized benefits with potential risks, including privacy affairs, due to the possibility of gaining confusing health information, or information that could generate unexpected emotions, misdiagnosis, and over-testing. In some regions, retail outlets are also including onsite testing for glucose and cholesterol as well as tests that are later sent out to reference laboratories. The growing spread of DTC tests across developing and developed regions is anticipated to drive the direct-to-consumer laboratory testing market during the forecast period.

Direct-to-Consumer Laboratory Testing Market: Overview

  • This report analyzes the current scenario and future prospects of the global direct-to-consumer laboratory testing market. Surge in demand for early disease detection & diagnosis coupled with personalized medicines, rise in prevalence of various lifestyle associated and infectious diseases, and increase in geriatric population are key factors that are projected to propel the global market during the forecast period.
  • The report includes an elaborate executive summary, which provides a snapshot of various segments of the global direct-to-consumer laboratory testing market. It also provides information and data analysis of the direct-to-consumer laboratory testing market about segments based on sample type, test type, end user, and region.
  • The overview section of the report provides a detailed qualitative analysis of drivers, restraints, and opportunities that affect the global direct-to-consumer laboratory testing market
  • The report includes company profiles, which provide information about their business, product portfolios, and competitive landscape in the global direct-to-consumer laboratory testing market
  • The report on the direct-to-consumer laboratory testing market offers market attractiveness analysis of regions and segments
  • The last section of the report comprises quantitative and qualitative analyses on market share/position of key players operating in the global direct-to-consumer laboratory testing market. It analyzes key competitive strategies adopted by major industry players, thereby presenting a thorough understanding of the competitive scenario in the global direct-to-consumer laboratory testing market.

Direct-to-Consumer Laboratory Testing Market: Key Segments

  • In terms of sample type, the global direct-to-consumer laboratory testing market has been classified into blood, urine, saliva, and others. The saliva segment is projected to account for a major share of the market. The segment’s dominance can be attributed to increase in the number of DTC testing companies offering saliva-based test kits.
  • Based on test type, the global direct-to-consumer laboratory testing market has been categorized into genetic testing, disease risk assessment testing, CBC, diabetes testing, TSH testing, and others. The disease risk assessment testing segment has been further split into cancer, STDs, and others. The genetic testing segment dominated the market in 2020. Number of users of DTC test kits for ancestry and health & fitness has increased at a rapid pace. The number of people interested in knowing about their ancestors and family tree has increased, which is also anticipated to increase the demand for DNA test kits, especially in developed countries across the globe.
  • In terms of end user, the global direct-to-consumer laboratory testing market has been classified into hospitals, clinics, specialty labs, and diagnostic centers. The diagnostic centers segment is projected to account for a major share of the market. Rise in the number of public–private partnerships is expected to drive the segment during the forecast period.
  • Market size and forecast for each of these segments have been provided from 2017 to 2031. The CAGR of respective segments has also been provided from 2021 to 2031, considering 2020 as the base year.

Direct-to-Consumer Laboratory Testing Market: Regional Outlook

  • In terms of region, the global direct-to-consumer laboratory testing market has been segmented into North America (U.S. and Canada), Europe (U.K., Germany, Spain, Italy, France, Switzerland, Russia and Rest of Europe), Asia Pacific (China, India, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (GCC Countries, South Africa, and Rest of Middle East & Africa). Each region considered in the market has been divided into countries/sub-regions.
  • The direct-to-consumer laboratory testing market report provides size and forecast for each region and country/sub-region from 2017 to 2031. The CAGR for each of these regions and countries has also been provided for the forecast period from 2021 to 2031. The direct-to-consumer laboratory testing market study also covers the competitive scenario in these regions.

Companies Covered in Direct-to-Consumer Laboratory Testing Market Report

  • Key players in the global direct-to-consumer laboratory testing market have been profiled based on attributes such as company overview, product portfolio, financial overview, recent developments, and competitive business strategies
  • Major companies profiled in the direct-to-consumer laboratory testing market report are
    • Laboratory Corporation of America Holdings
    • Quest Diagnostics Incorporated
    • 23andMe, Inc.
    • EverlyWell, Inc.
    • DirectLabs, LLC
    • Ancestry
    • MyMedLab, Inc.
    • WellnessFX
    • ANY LAB TEST NOW
    • LetsGetChecked
    • Color Genomics

Direct-to-Consumer Laboratory Testing Market – Segmentation

Sample Type
  • Blood
  • Urine
  • Saliva
  • Others
Test Type
  • Genetic Testing
  • Disease Risk Assessment Testing
    • Cancer
    • STDs
    • Others
  • CBC
  • Diabetes Testing
  • TSH Testing
  • Others
End User
  • Hospitals
  • Clinics
  • Specialty Labs
  • Diagnostic Centers
Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Frequently Asked Questions

What is the total market worth of direct-to-consumer laboratory testing market?

Direct-to-consumer laboratory testing market to surpass valuation of US$ 31.3 Bn by 2031

What is the anticipated CAGR of the direct-to-consumer laboratory testing market in the forecast period?

Direct-to-consumer laboratory testing market is projected to expand at a CAGR of 25.9% from 2021 to 2031

What are the key driving factors for the growth of the direct-to-consumer laboratory testing market?

Direct-to-consumer laboratory testing market is driven by rise in the demand for early disease detection & diagnosis coupled with personalized medicines

Which is the rising prominent segment in the direct-to-consumer laboratory testing market?

The genetic testing segment dominated the global direct-to-consumer laboratory testing market, and the trend is anticipated to continue during the forecast period

Who are the key players in the global direct-to-consumer laboratory testing market?

Key players operating in the global direct-to-consumer laboratory testing market are Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, and 23andMe, Inc., EverlyWell, Inc., DirectLabs

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary : Global Direct-to-Consumer Laboratory Testing Market

    4. Market Overview

        4.1. Introduction

            4.1.1. Product Definition

            4.1.2. Industry Evolution / Developments

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Direct-to-Consumer Laboratory Testing Market Analysis and Forecast, 2017–2031

            4.4.1. Market Revenue Projections (US$ Mn)

            4.4.2. Market Volume/Unit Shipments Projections

        4.5. Porter’s Five Force Analysis

    5. Key Insights

        5.1. Key Industrial Events (Licensing Partnership/Merger & Acquisition)

        5.2. Disease Prevalence & Incidence Rate

        5.3. Regulatory Scenario

        5.4. COVID-19 Pandemic Impact on Industry (Value Chain and Short / Mid / Long Term Impact)

    6. Global Direct-to-Consumer Laboratory Testing Market Analysis and Forecast, by Test Type

        6.1. Introduction & Definition

        6.2. Key Findings / Developments

        6.3. Global Direct-to-Consumer Laboratory Testing Market Value Forecast, by Test Type, 2017–2031

            6.3.1. Genetic testing

            6.3.2. Disease risk assessment testing

                6.3.2.1. Cancer

                6.3.2.2. STDs

                6.3.2.3. Others

            6.3.3. CBC

            6.3.4. Diabetes testing

            6.3.5. TSH testing

            6.3.6. Others

        6.4. Global Direct-to-Consumer Laboratory Testing Market Attractiveness, by Test Type

    7. Global Direct-to-Consumer Laboratory Testing Market Analysis and Forecast, by Sample Type

        7.1. Introduction & Definition

        7.2. Key Findings / Developments

        7.3. Global Direct-to-Consumer Laboratory Testing Market Value Forecast, by Sample Type , 2017–2031

            7.3.1. Blood

            7.3.2. Urine

            7.3.3. Saliva

            7.3.4. Others

        7.4. Global Direct-to-Consumer Laboratory Testing Market Attractiveness, by Sample Type

    8. Global Direct-to-Consumer Laboratory Testing Market Analysis and Forecast, by End-user

        8.1. Introduction & Definition

        8.2. Key Findings / Developments

        8.3. Global Direct-to-Consumer Laboratory Testing Market Value Forecast, by End-user, 2017–2031

            8.3.1. Hospitals

            8.3.2. Clinics

            8.3.3. Specialty labs

            8.3.4. Diagnostic centres

        8.4. Global Direct-to-Consumer Laboratory Testing Market Attractiveness, by End-user

    9. Global Direct-to-Consumer Laboratory Testing Market Analysis and Forecast, by Region

        9.1. Key Findings

        9.2. Global Direct-to-Consumer Laboratory Testing Market Value Forecast, by Region

            9.2.1. North America

            9.2.2. Europe

            9.2.3. Asia Pacific

            9.2.4. Latin America

            9.2.5. Middle East & Africa

        9.3. Global Direct-to-Consumer Laboratory Testing Market Attractiveness, by Country/Region

    10. North America Direct-to-Consumer Laboratory Testing Market Analysis and Forecast

        10.1. Introduction

            10.1.1. Key Findings

        10.2. North America Direct-to-Consumer Laboratory Testing Market Value Forecast, by Test Type, 2017–2031

            10.2.1. Genetic testing

            10.2.2. Disease risk assessment testing

                10.2.2.1. Cancer

                10.2.2.2. STDs

                10.2.2.3. Others

            10.2.3. CBC

            10.2.4. Diabetes testing

            10.2.5. TSH testing

            10.2.6. Others

        10.3. North America Direct-to-Consumer Laboratory Testing Market Value Forecast, by Sample Type, 2017–2031

            10.3.1. Blood

            10.3.2. Urine

            10.3.3. Saliva

            10.3.4. Others

        10.4. North America Direct-to-Consumer Laboratory Testing Market Value Forecast, by End-user, 2017–2031

            10.4.1. Hospitals

            10.4.2. Clinics

            10.4.3. Specialty labs

            10.4.4. Diagnostic centres

        10.5. North America Direct-to-Consumer Laboratory Testing Market Value Forecast, by Country, 2017–2031

            10.5.1. U.S.

            10.5.2. Canada

        10.6. North America Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis

            10.6.1. By Test Type 

            10.6.2. By Sample Type 

            10.6.3. By End-user

            10.6.4. By Country

    11. Europe Direct-to-Consumer Laboratory Testing Market Analysis and Forecast

        11.1. Introduction

            11.1.1. Key Findings

        11.2. Europe Direct-to-Consumer Laboratory Testing Market Value Forecast, by Test Type, 2017–2031

            11.2.1. Genetic testing

            11.2.2. Disease risk assessment testing

                11.2.2.1. Cancer

                11.2.2.2. STDs

                11.2.2.3. Others

            11.2.3. CBC

            11.2.4. Diabetes testing

            11.2.5. TSH testing

            11.2.6. Others

        11.3. Europe Direct-to-Consumer Laboratory Testing Market Value Forecast, by Sample Type, 2017–2031

            11.3.1. Blood

            11.3.2. Urine

            11.3.3. Saliva

            11.3.4. Others

        11.4. Europe Direct-to-Consumer Laboratory Testing Market Value Forecast, by End-user, 2017–2031

            11.4.1. Hospitals

            11.4.2. Clinics

            11.4.3. Specialty labs

            11.4.4. Diagnostic centres

        11.5. Europe Direct-to-Consumer Laboratory Testing Market Value Forecast, by Country/Sub-region, 2017–2031

            11.5.1. Germany

            11.5.2. U.K.

            11.5.3. France

            11.5.4. Spain

            11.5.5. Italy

            11.5.6. Rest of Europe

        11.6. Europe Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis

            11.6.1. By Test Type 

            11.6.2. By Sample Type 

            11.6.3. By End-user

            11.6.4. By Country/Sub-region

    12. Asia Pacific Direct-to-Consumer Laboratory Testing Market Analysis and Forecast

        12.1. Introduction

            12.1.1. Key Findings

        12.2. Asia Pacific Direct-to-Consumer Laboratory Testing Market Value Forecast, by Test Type, 2017–2031

            12.2.1. Genetic testing

            12.2.2. Disease risk assessment testing

                12.2.2.1. Cancer

                12.2.2.2. STDs

                12.2.2.3. Others

            12.2.3. CBC

            12.2.4. Diabetes testing

            12.2.5. TSH testing

            12.2.6. Others

        12.3. Asia Pacific Direct-to-Consumer Laboratory Testing Market Value Forecast, by Sample Type, 2017–2031

            12.3.1. Blood

            12.3.2. Urine

            12.3.3. Saliva

            12.3.4. Others

        12.4. Asia Pacific Direct-to-Consumer Laboratory Testing Market Value Forecast, by End-user, 2017–2031

            12.4.1. Hospitals

            12.4.2. Clinics

            12.4.3. Specialty labs

            12.4.4. Diagnostic centres

        12.5. Asia Pacific Direct-to-Consumer Laboratory Testing Market Value Forecast, by Country/Sub-region, 2017–2031

            12.5.1. China

            12.5.2. Japan

            12.5.3. India

            12.5.4. Australia & New Zealand

            12.5.5. Rest of Asia Pacific

        12.6. Asia Pacific Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis

            12.6.1. By Test Type 

            12.6.2. By Sample Type 

            12.6.3. By End-user

            12.6.4. By Country/Sub-region

    13. Latin America Direct-to-Consumer Laboratory Testing Market Analysis and Forecast

        13.1. Introduction

            13.1.1. Key Findings

        13.2. Latin America Direct-to-Consumer Laboratory Testing Market Value Forecast, by Test Type, 2017–2031

            13.2.1. Genetic testing

            13.2.2. Disease risk assessment testing

                13.2.2.1. Cancer

                13.2.2.2. STDs

                13.2.2.3. Others

            13.2.3. CBC

            13.2.4. Diabetes testing

            13.2.5. TSH testing

            13.2.6. Others

        13.3. Latin America Direct-to-Consumer Laboratory Testing Market Value Forecast, by Sample Type, 2017–2031

            13.3.1. Blood

            13.3.2. Urine

            13.3.3. Saliva

            13.3.4. Others

        13.4. Latin America Direct-to-Consumer Laboratory Testing Market Value Forecast, by End-user, 2017–2031

            13.4.1. Hospitals

            13.4.2. Clinics

            13.4.3. Specialty labs

            13.4.4. Diagnostic centres

        13.5. Latin America Direct-to-Consumer Laboratory Testing Market Value Forecast, by Country/Sub-region, 2017–2031

            13.5.1. Brazil

            13.5.2. Mexico

            13.5.3. Rest of Latin America

        13.6. Market Attractiveness Analysis

            13.6.1. By Test Type 

            13.6.2. By Sample Type 

            13.6.3. By End-user

            13.6.4. By Country/Sub-region

    14. Middle East & Africa Direct-to-Consumer Laboratory Testing Market Analysis and Forecast

        14.1. Introduction

            14.1.1. Key Findings

        14.2. Middle East & Africa Direct-to-Consumer Laboratory Testing Market Value Forecast, by Test Type, 2017–2031

            14.2.1. Genetic testing

            14.2.2. Disease risk assessment testing

                14.2.2.1. Cancer

                14.2.2.2. STDs

                14.2.2.3. Others

            14.2.3. CBC

            14.2.4. Diabetes testing

            14.2.5. TSH testing

            14.2.6. Others

        14.3. Middle East & Africa Direct-to-Consumer Laboratory Testing Market Value Forecast, by Sample Type, 2017–2031

            14.3.1. Blood

            14.3.2. Urine

            14.3.3. Saliva

            14.3.4. Others

        14.4. Middle East & Africa Direct-to-Consumer Laboratory Testing Market Value Forecast, by End-user, 2017–2031

            14.4.1. Hospitals

            14.4.2. Clinics

            14.4.3. Specialty labs

            14.4.4. Diagnostic centers

        14.5. Middle East & Africa Direct-to-Consumer Laboratory Testing Market Value Forecast, by Country/Sub-region, 2017–2031

            14.5.1. GCC Countries

            14.5.2. South Africa

            14.5.3. Rest of Middle East & Africa

        14.6. Middle East & Africa Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis

            14.6.1. By Test Type 

            14.6.2. By Sample Type

            14.6.3. By End-user

            14.6.4. By Country/Sub-region

    15. Competition Landscape

        15.1. Company Profiles

            15.1.1. Laboratory Corporation of America Holdings

                15.1.1.1. Company Overview

                15.1.1.2. Company Financials

                15.1.1.3. Growth Strategies

                15.1.1.4. SWOT Analysis

            15.1.2. Quest Diagnostics Incorporated

                15.1.2.1. Company Overview

                15.1.2.2. Company Financials

                15.1.2.3. Growth Strategies

                15.1.2.4. SWOT Analysis

            15.1.3. 23andMe, Inc.

                15.1.3.1. Company Overview

                15.1.3.2. Company Financials

                15.1.3.3. Growth Strategies

                15.1.3.4. SWOT Analysis

            15.1.4. EverlyWell, Inc

                15.1.4.1. Company Overview

                15.1.4.2. Company Financials

                15.1.4.3. Growth Strategies

                15.1.4.4. SWOT Analysis

            15.1.5. DirectLabs, LLC

                15.1.5.1. Company Overview

                15.1.5.2. Company Financials

                15.1.5.3. Growth Strategies

                15.1.5.4. SWOT Analysis

            15.1.6. Ancestry

                15.1.6.1. Company Overview

                15.1.6.2. Company Financials

                15.1.6.3. Growth Strategies

                15.1.6.4. SWOT Analysis

            15.1.7. MyMedLab, Inc.

                15.1.7.1. Company Overview

                15.1.7.2. Company Financials

                15.1.7.3. Growth Strategies

                15.1.7.4. SWOT Analysis

            15.1.8. WellnessFX

                15.1.8.1. Company Overview

                15.1.8.2. Company Financials

                15.1.8.3. Growth Strategies

                15.1.8.4. SWOT Analysis

            15.1.9. ANY LAB TEST NOW

                15.1.9.1. Company Overview

                15.1.9.2. Company Financials

                15.1.9.3. Growth Strategies

                15.1.9.4. SWOT Analysis

            15.1.10. LetsGetChecked

                15.1.10.1. Company Overview

                15.1.10.2. Company Financials

                15.1.10.3. Growth Strategies

                15.1.10.4. SWOT Analysis

            15.1.11. Color Genomics

                15.1.11.1. Company Overview

                15.1.11.2. Company Financials

                15.1.11.3. Growth Strategies

                15.1.11.4. SWOT Analysis

    List of Tables

    Table 01: Global Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031

    Table 02: Global Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031

    Table 03: Global Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Disease Risk assessment testing, 2017–2031

    Table 04: Global Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 05: Global Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Region, 2017–2031

    Table 06: North America Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Country, 2017–2031

    Table 07: North America Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031

    Table 08: North America Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031

    Table 09: North America Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Disease Risk Assessment Testing, 2017–2031

    Table 10: North America Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 11: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 12: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031

    Table 13: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031

    Table 14: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Disease Risk Assessment Testing, 2017–2031

    Table 15: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 16: Asia Pacific Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 17: Asia Pacific Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031

    Table 18: Asia Pacific Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031

    Table 19: Asia Pacific Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Disease Risk Assessment Testing, 2017–2031

    Table 20: Asia Pacific Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 21: Latin America Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 22: Latin America Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031

    Table 23: Latin America Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031

    Table 24: Latin America Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Disease Risk Assessment Testing, 2017–2031

    Table 25: Latin America Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 26: Middle East & Africa Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 27: Middle East & Africa Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031

    Table 28: Middle East & Africa Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031

    Table 29: Middle East & Africa Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Disease Risk Assessment Testing, 2017–2031

    Table 30: Middle East & Africa Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    List of Figure

    Figure 01: Global Direct-to-Consumer Laboratory Testing Market Value Share, by Sample Type, 2020

    Figure 02: Global Direct-to-Consumer Laboratory Testing Market Value Share, by Test Type, 2020

    Figure 03: Global Direct-to-Consumer Laboratory Testing Market Value Share, by End-user, 2020

    Figure 04: Global Direct-to-Consumer Laboratory Testing Market Value Share, by Region, 2020

    Figure 05: Global Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Sample Type, 2020 and 2031

    Figure 06: Global Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Sample Type, 2021–2031

    Figure 07: Global Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Blood, 2017–2031

    Figure 08: Global Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Saliva, 2017–2031

    Figure 09: Global Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Urine, 2017–2031

    Figure 10: Global Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Others, 2017–2031

    Figure 11: Global Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Test Type, 2020 and 2031

    Figure 12: Global Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Test Type, 2021–2031

    Figure 13: Global Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Genetic testing, 2017–2031

    Figure 14: Global Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Disease Risk assessment testing, 2017–2031

    Figure 15: Global Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Coronary Research, 2017–2031

    Figure 16: Global Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Non-coronary /Peripheral Test Types, 2017–2031

    Figure 17: Global Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Coronary Research, 2017–2031

    Figure 18: Global Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Non-coronary /Peripheral Test Types, 2017–2031

    Figure 19: Global Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by End-user, 2020 and 2031

    Figure 20: Global Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by End-user, 2021–2031

    Figure 21: Global Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Hospitals, 2017–2031

    Figure 22: Global Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Clinics, 2017–2031

    Figure 23: Global Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Specialty Labs, 2017–2031

    Figure 24: Global Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Diagnostic Centres, 2017–2031

    Figure 25: Global Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Region, 2020 and 2031

    Figure 26: Global Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Region, 2021–2031

    Figure 27: North America Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

    Figure 28: North America Direct-to-Consumer Laboratory Testing Market Value Share, by Country, 2020 and 2031

    Figure 29: North America Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Country, 2021–2031

    Figure 30: North America Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Sample Type, 2020 and 2031

    Figure 31: North America Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Sample Type, 2021–2031

    Figure 32: North America Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Test Type, 2020 and 2031

    Figure 33: North America Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Test Type, 2021–2031

    Figure 34: North America Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by End-user, 2020 and 2031

    Figure 35: North America Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by End-user, 2021–2031

    Figure 36: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

    Figure 37: Europe Direct-to-Consumer Laboratory Testing Market Value Share, by Country/Sub-region, 2020 and 2031

    Figure 38: Europe Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

    Figure 39: Europe Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Sample Type, 2020 and 2031

    Figure 40: Europe Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Sample Type, 2021–2031

    Figure 41: Europe Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Test Type, 2020 and 2031

    Figure 42: Europe Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Test Type, 2021–2031

    Figure 43: Europe Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by End-user, 2020 and 2031

    Figure 44: Europe Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by End-user, 2021–2031

    Figure 45: Asia Pacific Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

    Figure 46: Asia Pacific Direct-to-Consumer Laboratory Testing Market Value Share, by Country/Sub-region, 2020 and 2031

    Figure 47: Asia Pacific Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

    Figure 48: Asia Pacific Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Sample Type, 2020 and 2031

    Figure 49: Asia Pacific Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Sample Type, 2021–2031

    Figure 50: Asia Pacific Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Test Type, 2020 and 2031

    Figure 51: Asia Pacific Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Test Type, 2021–2031

    Figure 52: Asia Pacific Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by End-user, 2020 and 2031

    Figure 53: Asia Pacific Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by End-user, 2021–2031

    Figure 54: Latin America Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

    Figure 55: Latin America Direct-to-Consumer Laboratory Testing Market Value Share, by Country/Sub-region, 2020 and 2031

    Figure 56: Latin America Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

    Figure 57: Latin America Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Sample Type, 2020 and 2031

    Figure 58: Latin America Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Sample Type, 2021–2031

    Figure 59: Latin America Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Test Type, 2020 and 2031

    Figure 60: Latin America Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Test Type, 2021–2031

    Figure 61: Latin America Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by End-user, 2020 and 2031

    Figure 62: Latin America Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by End-user, 2021–2031

    Figure 63: Middle East & Africa Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

    Figure 64: Middle East & Africa Direct-to-Consumer Laboratory Testing Market Value Share, by Country/Sub-region, 2020 and 2031

    Figure 65: Middle East & Africa Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

    Figure 66: Middle East & Africa Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Sample Type, 2020 and 2031

    Figure 67: Middle East & Africa Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Sample Type, 2021–2031

    Figure 68: Middle East & Africa Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Test Type, 2020 and 2031

    Figure 69: Middle East & Africa Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Test Type, 2021–2031

    Figure 70: Middle East & Africa Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by End-user, 2020 and 2031

    Figure 71: Middle East & Africa Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by End-user, 2021–2031

    Figure 72: Position Analysis, 2020, by Tier and Size of the Company

    Figure 73: Breakdown of Net Sales (%), by Business Segment, 2020

    Figure 74: Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2020

    Figure 75: Breakdown of Net Sales (%), by Business Segment, 2020

    Figure 76: Breakdown of Net Sales (%), by Region, 2020

    Figure 77: Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2020

Copyright © Transparency Market Research, Inc. All Rights reserved